أعرض في EDS

Progression-free survival with first line treatment as prognostic factor of treatment success in subsequent lines in lung adenocarcinoma patients – who´s the 'good responder'?

التفاصيل البيبلوغرافية
العنوان:	Progression-free survival with first line treatment as prognostic factor of treatment success in subsequent lines in lung adenocarcinoma patients – who´s the 'good responder'?
المؤلفون:	Martin Svaton, Michal Hrnčiarik, Leona Koubková, Jana Skrickova, Monika Bratová, Daniel Dolezal, Jana Krejčí, Libor Havel, Martin Safanda, Helena Čoupková, Magda Barinova, Marketa Cernovska, Juraj Kultan, Kristián Brat, Ondrej Fischer, Tana Tuzova, Milada Zemanova, Karolina Hurdalkova, Miloš Pešek
المصدر:	Lung cancer.
بيانات النشر:	European Respiratory Society, 2021.
سنة النشر:	2021
مصطلحات موضوعية:	Oncology, medicine.medical_specialty, Prognostic factor, Lung, business.industry, medicine.disease, First line treatment, medicine.anatomical_structure, Treatment success, Internal medicine, medicine, Adenocarcinoma, Progression-free survival, business
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::a4c505604a7e449adfb38275957c2e3e https://doi.org/10.1183/13993003.congress-2021.pa2306
رقم الأكسشن:	edsair.doi...........a4c505604a7e449adfb38275957c2e3e
قاعدة البيانات:	OpenAIRE

الوصف
الوصف غير متاح.